Small study looks only at a cardiac biomarker; findings are in line with reduced myocarditis risk in mRNA COVID vaccines ...
A shot analysts projected as a multibillion-dollar seller produced results “well below” the company’s expectations, ...
Moderna is halting development of an mRNA vaccine for congenital cytomegalovirus after its candidate failed to protect women ...
GlobalData on MSN
Moderna scraps mRNA vaccine in congenital CMV on Phase III failure
While development has been scrapped in CMV, a Phase II trial investigating the candidate in bone marrow transplant patients ...
Moderna said its experimental vaccine for cytomegalovirus failed in a key trial, a significant setback for a company already ...
A key question for investors going forward will be whether Moderna's other latent virus vaccines for Epstein-Barr and ...
Moderna’s oncology pipeline also includes a Merck-partnered personalized cancer vaccine called intismeran autogene or ...
Moderna ends its CMV vaccine program after a Phase 3 trial failed to meet efficacy goals, but maintains its 2028 breakeven ...
NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...
LOS ANGELES -- The COVID-19 vaccines made by Pfizer and Moderna both require two doses to be administered, several weeks apart, for them to be fully effective. But there has been some scientific ...
HOUSTON, Texas (KTRK) -- Moderna is launching a new vaccine trial called KidCOVE, and it's the largest vaccine study of its kind aimed at children to fight COVID-19. The good news is your child could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback